Completed EARLY_PHASE1 INTERVENTIONAL 3-arm NCT01688570

Mechanisms of Neuromuscular Fatigue Post Stroke

Sponsor: Medical College of Wisconsin

Conditions Stroke

Interventions Cyproheptadine Placebo duloxetine

Updated 6 times since 2017 Last updated: Nov 4, 2015 Started: Aug 31, 2011 Primary completion: May 31, 2015 Completion: May 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01688570, this EARLY_PHASE1 trial focuses on Stroke and remains completed. Sponsored by Medical College of Wisconsin, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed Phase 0

First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical College of Wisconsin

Data source: Medical College of Wisconsin

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milwaukee, United States